José Lastiri
About
In The Last Decade
José Lastiri
20 papers receiving 531 citations
Peers
Comparison fields: 5 of 64
- Molecular Biology 210
- Oncology 204
- Surgery 116
- Immunology 95
- Genetics 88
Countries citing papers authored by José Lastiri
This map shows the geographic impact of José Lastiri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by José Lastiri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites José Lastiri more than expected).
Fields of papers citing papers by José Lastiri
This network shows the impact of papers produced by José Lastiri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by José Lastiri. The network helps show where José Lastiri may publish in the future.
Co-authorship network of co-authors of José Lastiri
This figure shows the co-authorship network connecting the top 25 collaborators of José Lastiri. A scholar is included among the top collaborators of José Lastiri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with José Lastiri. José Lastiri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 23 | |
| 3 | 19 | |
| 4 | 1 | |
| 5 | 29 | |
| 6 | 29 | |
| 7 | 19 | |
| 8 | 85 | |
| 9 | Retinoides (RARβ y CRBP1) en carcinoma de pulmón a células no pequeñas | 1 |
| 10 | [Retinoid expression (RARbeta and CRBP1) in non-small-cell lung carcinoma]. | 3 |
| 11 | 35 | |
| 12 | 56 | |
| 13 | 30 | |
| 14 | 48 | |
| 15 | 57 | |
| 16 | 27 | |
| 17 | 1 | |
| 18 | [Predictive response variables to recombinant human erythropoietin treatment in patients with anemia and cancer]. | 7 |
| 19 | 16 | |
| 20 | 52 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.